Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2025
19 Nov 2025The FDA's 2025 update to biosimilar approval rules cuts development time and cost by relying on advanced science instead of lengthy clinical trials. Learn how biosimilars are reviewed, why they're cheaper, and what's holding back wider use.